222
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Weighted Gene Co-Expression Network Analysis of Oxymatrine in Psoriasis Treatment

ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 845-859 | Received 26 Dec 2022, Accepted 17 Feb 2023, Published online: 07 Mar 2023

References

  • Christophers E. Psoriasis − epidemiology and clinical spectrum. Clin Exp Dermatol. 2001;26(4):314–320. doi:10.1046/j.1365-2230.2001.00832.x
  • Lockshin B, Balagula Y, Merola JF. Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis. J Am Acad Dermatol. 2018;79(2):345–352.
  • Gisondi P, Del Giglio M, Girolomoni G. Treatment approaches to moderate to severe psoriasis. Int J Mol Sci. 2017;18:11.
  • Turbeville JG, Patel NU, Cardwell LA, Oussedik E, Feldman SR. Recent advances in small molecule and biological therapeutic approaches in the treatment of psoriasis. Clin Pharmacol Ther. 2017;102(1):70–85.
  • Greb JE, Goldminz AM, Elder JT, et al. Psoriasis. Nat Rev Dis Primers. 2016;2:16082.
  • Monteleone G, Pallone F, MacDonald TT, Chimenti S, Costanzo A. Psoriasis: from pathogenesis to novel therapeutic approaches. Clin Sci (Lond). 2011;120(1):1–11.
  • Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323(19):1945–1960.
  • Narla S, Silverberg JI, Simpson EL. Management of inadequate response and adverse effects to dupilumab in atopic dermatitis. J Am Acad Dermatol. 2022;86(3):628–636.
  • Lebwohl M. Psoriasis. Ann Intern Med. 2018;168(7):ITC49–ITC64.
  • Rønholt K, Iversen L. Old and new biological therapies for psoriasis. Int J Mol Sci. 2017;18(11):11. doi:10.3390/ijms18112297
  • Zhang X, Jin L, Cui Z, et al. Antiparasitic effects of oxymatrine and matrine against Toxoplasma gondii in vitro and in vivo. Exp Parasitol. 2016;165:95–102. doi:10.1016/j.exppara.2016.03.020
  • Lan X, Zhao J, Zhang Y, Chen Y, Liu Y, Xu F. Oxymatrine exerts organ- and tissue-protective effects by regulating inflammation, oxidative stress, apoptosis, and fibrosis: from bench to bedside. Pharmacol Res. 2020;151:104541.
  • Jiang X, Xie L, Huang C, et al. Oral oxymatrine for hepatitis B cirrhosis: a systematic review protocol. Medicine. 2018;97(49):e13482.
  • Jiang Y, Zhu Y, Mu Q, Luo H, Zhi Y, Shen X. Oxymatrine provides protection against Coxsackievirus B3-induced myocarditis in BALB/c mice. Antivir Res. 2017;141:133–139.
  • Guo L, Yang T. Oxymatrine inhibits the proliferation and invasion of breast cancer cells via the pi3k pathway. Cancer Manag Res. 2019;11:10499–10508.
  • Zhang W, Zhang J, Liu YK, et al. Cardioprotective effects of oxymatrine on isoproterenol-induced heart failure via regulation of DDAH/ADMA metabolism pathway in rats. Eur J Pharmacol. 2014;745:29–35.
  • Li W, Yu X, Tan S, Liu W, Zhou L, Liu H. Oxymatrine inhibits non-small cell lung cancer via suppression of EGFR signaling pathway. Cancer Med. 2018;7(1):208–218.
  • Guo C, Han F, Zhang C, Xiao W, Yang Z. Protective effects of oxymatrine on experimental diabetic nephropathy. Planta Med. 2014;80(4):269–276.
  • Zhang B, Niu W, Xu D, et al. Oxymatrine prevents hypoxia- and monocrotaline-induced pulmonary hypertension in rats. Free Radic Biol Med. 2014;69:198–207.
  • Chen Q, Zhou H, Yang Y, et al. Investigating the potential of oxymatrine as a psoriasis therapy. Chem Biol Interact. 2017;271:59–66.
  • Zhang H, Yang L, Wang Y, et al. Oxymatrine alleviated hepatic lipid metabolism via regulating miR-182 in non-alcoholic fatty liver disease. Life Sci. 2020;257:118090.
  • Xue X, Yu J, Li C, et al. Full-length transcriptome sequencing analysis of differentially expressed genes and pathways after treatment of psoriasis with oxymatrine. Front Pharmacol. 2022;13:889493.
  • Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9:559.
  • Liao Y, Wang Y, Cheng M, Huang C, Fan X. Weighted gene coexpression network analysis of features that control cancer stem cells reveals prognostic biomarkers in lung adenocarcinoma. Front Genet. 2020;11:311.
  • Shi S, Tian B. Identification of biomarkers associated with progression and prognosis in bladder cancer via co-expression analysis. Cancer Biomark. 2019;24(2):183–193.
  • Xiong Y, Yuan L, Chen L, et al. Identifying a novel biomarker TOP2A of clear cell renal cell carcinoma (ccRCC) associated with smoking by co-expression network analysis. J Cancer. 2018;9(21):3912–3922.
  • Zhou XG, Huang XL, Liang SY, et al. Identifying miRNA and gene modules of colon cancer associated with pathological stage by weighted gene co-expression network analysis. Onco Targets Ther. 2018;11:2815–2830.
  • Huang W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37(1):1–13.
  • Wu J, Mao X, Cai T, Luo J, Wei L. KOBAS server: a web-based platform for automated annotation and pathway identification. Nucleic Acids Res. 2006;34:W720–4.
  • Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287.
  • Shi HJ, Zhou H, Ma AL, et al. Oxymatrine therapy inhibited epidermal cell proliferation and apoptosis in severe plaque psoriasis. Br J Dermatol. 2019;181(5):1028–1037.
  • Hawkes JE, Yan BY, Chan TC, Krueger JG. Discovery of the IL-23/IL-17 signaling pathway and the treatment of psoriasis. J Immunol. 2018;201(6):1605–1613.
  • Tervaniemi MH, Katayama S, Skoog T, et al. NOD-like receptor signaling and inflammasome-related pathways are highlighted in psoriatic epidermis. Sci Rep. 2016;6:22745.
  • Bunte K, Beikler T. Th17 Cells and the IL-23/IL-17 axis in the pathogenesis of periodontitis and immune-mediated inflammatory diseases. Int J Mol Sci. 2019;20(14):58.
  • Brembilla NC, Senra L, Boehncke WH. The IL-17 family of cytokines in psoriasis: IL-17A and beyond. Front Immunol. 2018;9:1682.
  • Zou A, Jian Q. CXCL10 and its related key genes as potential biomarkers for psoriasis: evidence from bioinformatics and real-time quantitative polymerase chain reaction. Medicine. 2021;100(38):e27365.
  • Goodwin P, Hamilton S, Fry L. The cell cycle in psoriasis. Br J Dermatol. 1974;90(5):517–524.
  • Pasquali L, Srivastava A, Meisgen F, et al. The keratinocyte transcriptome in psoriasis: pathways related to immune responses, cell cycle and keratinization. Acta Derm Venereol. 2019;99(2):196–205.
  • Nickoloff BJ, Xin H, Nestle FO, Qin JZ. The cytokine and chemokine network in psoriasis. Clin Dermatol. 2007;25(6):568–573.
  • Guarneri F, Custurone P, Papaianni V, Gangemi S. Involvement of RAGE and oxidative stress in inflammatory and infectious skin diseases. Antioxidants. 2021;10:1.
  • Mezentsev AV, Bruskin SA, Soboleva AG, Sobolev VV, Piruzian ES. Pharmacological control of receptor of advanced glycation end-products and its biological effects in psoriasis. Int J Biomed Sci. 2013;9(3):112–122.
  • Kypriotou M, Huber M, Hohl D. The human epidermal differentiation complex: cornified envelope precursors, S100 proteins and the ‘fused genes’ family. Exp Dermatol. 2012;21(9):643–649.
  • Oh IY. The molecular revolution in cutaneous biology: EDC and locus control. J Invest Dermatol. 2017;137(5):e101–e4.
  • Williams RR, Broad S, Sheer D, Ragoussis J. Subchromosomal positioning of the epidermal differentiation complex (EDC) in keratinocyte and lymphoblast interphase nuclei. Exp Cell Res. 2002;272(2):163–175.
  • Hoffjan S, Stemmler S. On the role of the epidermal differentiation complex in ichthyosis vulgaris, atopic dermatitis and psoriasis. Br J Dermatol. 2007;157(3):441–449.
  • Wagner T, Beer L, Gschwandtner M, et al. The differentiation-associated keratinocyte protein cornifelin contributes to cell-cell adhesion of epidermal and mucosal keratinocytes. J Invest Dermatol. 2019;139(11):2292–2301.e9.
  • Abhishek S, Palamadai Krishnan S. Epidermal differentiation complex: a review on its epigenetic regulation and potential drug targets. Cell J. 2016;18(1):1–6.
  • Michibata H, Chiba H, Wakimoto K, et al. Identification and characterization of a novel component of the cornified envelope, cornifelin. Biochem Biophys Res Commun. 2004;318(4):803–813.
  • Wang S, Song R, Wang Z, Jing Z, Wang S, Ma J. S100A8/A9 in inflammation. Front Immunol. 2018;9:1298.
  • Gibbs S, Fijneman R, Wiegant J, van Kessel AG, van De Putte P, Backendorf C. Molecular characterization and evolution of the SPRR family of keratinocyte differentiation markers encoding small proline-rich proteins. Genomics. 1993;16(3):630–637.
  • Koizumi H, Kartasova T, Tanaka H, Ohkawara A, Kuroki T. Differentiation-associated localization of small proline-rich protein in normal and diseased human skin. Br J Dermatol. 1996;134(4):686–692.
  • Kartasova T. Isolation, characterization, and UV-stimulated expression of two families of genes encoding polypeptides of related structure in human epidermal keratinocytes. Mol Cell Biol. 1988;8(5):2195–2203.